Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Sun Pharmaceutical Industries Europe B.V., Polarisavenue 87, 2132 JH Hoofddorp, The Netherlands
Sunveniz XL 75 mg prolonged-release tablets.
| Pharmaceutical Form |
|---|
|
Prolonged-release tablet. The prolonged-release tablet is round, pink and white coloured biconvex, 8.4 mm in diameter bilayer coated tablet imprinted with “759” with black ink on one side and plain on the other side. |
Sunveniz XL 75 mg: Each prolonged-release tablet contains 75 mg of venlafaxine (as venlafaxine hydrochloride).
Excipients with known effect: Each prolonged-release tablet contains 83.26 mg of lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Venlafaxine |
Venlafaxine has an antidepressant effect. The mechanism of its action in humans is believed to be associated with its potentiation of neurotransmitter activity in the central nervous system. |
| List of Excipients |
|---|
|
Tablet core: Sustained release layer: Methyl hydroxypropyl cellulose Openable layer: Microcrystalline cellulose silicified Coating: Ethylcellulose aqueous dispersion Opadry II 85F19250 clear which consists of: talc, macrogol 3350, polysorbate 80, polyvinyl alcohol Printing ink (opacode-s-1-17823 black ink): shellac, iron oxide black (E172), propylene glycol |
Blister consisting of an OPA (oriented Poly Amide) / Aluminium / PVC (Polyvinyl chloride) film and Paper / PET (Polyethylene terephthalate) / Aluminium / Peelable lidding foil with heat seal lacquer.
Pack sizes: 14, 15, 20, 28, 30, 50 or 100 prolonged-release tablets.
HDPE tablet container along with silica gel canister closed with child resistant closure.
Pack sizes: 30 or 1000 (for dispensing only) prolonged release tablets.
Not all pack sizes may be marketed.
Sun Pharmaceutical Industries Europe B.V., Polarisavenue 87, 2132 JH Hoofddorp, The Netherlands
Sunveniz XL 75 mg prolonged-release tablets: PL31750/0026
Date of first authorisation: 10/12/2010
Date of latest renewal: 05/10/2015
| Drug | Countries | |
|---|---|---|
| SUNVENIZ | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
